Cardiovascular Renal Metabolic

THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s

Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al

Read time: 20m 9s

Dinesh Khullar , Anish Kumar Gupta , Kulwant Singh

Read time: 21m 40s

Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al

Read time: 37m 48s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease

William Herrington

Watch time: 8m 11s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar

Joost Daemen, Nicolas M Van Mieghem

View from the Thoraxcenter: AHA 24 Late-breaking Preview

Listen time: 13m 44s
View from the Thoraxcenter: What's Hot at AHA 24?

Joost Daemen, Nicolas M Van Mieghem

Watch time: 13m 43s

Muthiah Vaduganathan

Giuseppe Rosano , David Quek , Felipe Martínez

Read time: 10m

Sydney Tang et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Clara Bonanad Lozano , Anjay Rastogi

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Navdeep Tangri, James Burton, David Wheeler et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al

Read time: 18m 10s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)
Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice

Muthiah Vaduganathan, ,

Listen time: 20m 40s

Media

ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s

Shelley Zieroth, Stefan Anker

Watch time: 1h 5m 13s (5 videos)

Andrew JS Coats, Harriette Van Spall, Faiez Zannad et al

Watch time: 49m 1s (3 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)
Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler

Javed Butler

Watch time: 5m 13s
ACC 2018: Canagliflozin & heart failure in type 2 diabetes

Gemma Figtree

Watch time: 3m 13s
ESC 2019: A review of SGLT2 inhibitors in HF - Prof Marc Sabatine & Prof Lars Kober

Marc S Sabatine, Lars Kober

Watch time: 14m 37s
Lars Lund - SGTL2i beyond diabetes

Lars H Lund

Watch time: 8m 5s
image

Lars H Lund

Watch time: 8m 5s
image

Felipe Martínez

Watch time: 5m 9s
DAPA-HF: A discussion with the trialist

John JV McMurray, Mikhail Kosiborod

Watch time: 19m 18s

Articles

The True Obesity Paradox: Obese and Malnourished?

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

Sandra Henriette Tonning

,

Ida Arentz Taraldsen

,

Frederik Dencker Wisborg

,

Ove Andersen

,

Jens Dahlgaard Hove

,

Johannes Grand

,

Published:

19 February 2025

Citation:

Cardiac Failure Review 2025;11:e03.

DOI:

https://doi.org/10.15420/cfr.2024.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 519
  • Downloads: Downloads 34
  • Read time: 20m 9s

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3203
  • Downloads: Downloads 207
  • Read time: 21m 40s

Aldosterone and Potassium in Heart Failure

Laibah Arshad Khan

,

Adeena Jamil

,

Stephen J Greene

,

Muhammad Shahzeb Khan

,

Javed Butler

,

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

DOI:

https://doi.org/10.15420/cfr.2024.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1718
  • Downloads: Downloads 172
  • Read time: 37m 48s

GLP-1RA in Different HFpEF Phenotypes

Aleksandra Bykova

,

Maria Serova

,

Maria Chashkina

,

Raisa Kosharnaya

,

Zukhra Salpagarova

,

Denis Andreev

,

Ilya Giverts

,

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.

DOI:

https://doi.org/10.15420/cfr.2024.06
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1693
  • Downloads: Downloads 176
  • Read time: 22m 11s